|
Overview
| Changes in gene expression underlie many biological phenomena. Real-time quantitative PCR is a highly sensitive method that utilizes small sample sizes and short experimental time frames. qPCR is especially useful for evaluating "RNA fingerprints" obtained from microarray or siRNA experiments. These gene expression technologies generate vast amounts of data. Yet, there are often limited resources for subsequent independent validation studies. Cost, time, reagents, kit selection, and instrumentation considerations are crucial. Researchers, using microarrays or RNAi for mapping cellular pathways, prioritizing suitable targets for pharmaceutical intervention or diagnostics, determining toxicology or prognostics (disease progression), will find this meeting useful for developing qPCR as their validation tool of choice. |
|
|
|
• Pre-Conference Short Course
Tutorial
• Kick-Off Panel and a “Lessons
Learned” Wrap-Up Panel
• Premier Resort Location
• Solution Showcase Sessions
• Interactive Roundtable Discussion
• Networking Opportunities with the
Industry's Top Leaders
• Present a Poster and save $50
|
|
|
| Scientific Advisors |
Dr. Stephen Bustin, University of London
Dr. Gregory Shipley, University of Texas Houston Medical School
Mr. Neven Zoric, TATAA Biocenter AB |
| |
| Distinguished Faculty |
|
Mr. Morten Andersen, LGC, Ltd.
Dr. Michael J. Antinore, Epoch Biosciences
Mr. Herbert Auer, Ohio State University
Dr. Stephen A. Bustin, University of London
Dr. Lorrie Daggett, Merk Research Labs
Dr. Wuxiong Cao, Sanofi-Aventis
Dr. Antoine Daridon, Fluidigm Corporation
Dr. Eric Fedyk, Millennium Pharmaceuticals Inc.
Dr. Richard Hockett, Eli Lilly & Co.
Dr. Marcia Holden, NIST
Dr. Michael J. Holland, University of California- Davis
Dr. Sergey Ilyin, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Dr. Sandrine Javorschi-Miller, Invitrogen Corporation
Dr. Ricardo Mancebo, Applied Biosystems
Dr. Wolfgang Mann, ALOPEX
Dr. Reinhold Mueller, Stratagene
Dr. Mikkel Noerholm, Exiqon A/S
Dr. John Pfeifer, Applied Biosystems
Dr. Stephen Sharp, Sequenom, Inc.
Dr. Gregory Shipley, University of Texas Houston Medical School
Dr. Richard Shippy, GE Healthtcare
Dr. Michael Showe, The Wistar Institute
Ms. Melanie A. Yanek, ABgene
Dr. Lawrence J. Wangh, Brandeis University
Dr. Janet Warrington, Affymetrix
Dr. James Willey, Gene Express, Inc.
Dr. P. Mickey Williams, Roche Molecular Systems
Dr. Paul K. Wolber, Agilent Technologies
Mr. Neven Zoric, TATAA Biocenter AB
|
Sponsorship Opportunities
Showcase your company's expertise, brand your solutions and develop revenue
opportunities with qualified decision-makers by becoming a sponsor of
Quantitative PCR. If you'd like to discuss various sponsorship opportunities,
please contact Angela Parsons at 781-972-5467, or aparsons@healthtech.com.
Exhibit list:
ABgene
Applied Biosystems
BD Biosciences CLONETECH
Bio Rad Laboratories
Biosearch Technologies
Biotage
BioTrove
Eppendorf
Eurogentec North America Inc.
Exiqon
Finnzymes Oy
Gene Express
Invitrogen
Nanogen
Sequenom
Stratagene
|
